APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bifidobacterium Animalis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bifidobacterium Animalis Market Outlook and Growth Opportunities 2026

24 December 2025196 pages

Choose your research edition.

Industry ResearchBifidobacterium Animalis Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Bifidobacterium Animalis Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Bifidobacterium Animalis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bifidobacterium Animalis Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Bifidobacterium Animalis Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Bifidobacterium Animalis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bifidobacterium Animalis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bifidobacterium Animalis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bifidobacterium Animalis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bifidobacterium Animalis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bifidobacterium Animalis market include ADM, ATCC, Chr. Hansen, Creative Biolabs, DuPont Nutrition & Biosciences, Fengchen Group, Microbiologics, Morinaga and SynBalance, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bifidobacterium Animalis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bifidobacterium Animalis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bifidobacterium Animalis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bifidobacterium Animalis market size, projected growth trends, production technologies, key applications, and end-use industries.

Bifidobacterium Animalis Segment by Company

ADM

ATCC

Chr. Hansen

Creative Biolabs

DuPont Nutrition & Biosciences

Fengchen Group

Microbiologics

Morinaga

SynBalance

BGI Nutri

Wecare Probiotics

Yili Group

Wisbiom (Beijing) Biotechnology

Bifidobacterium Animalis Segment by Type

Bifidobacterium Animalis Subsp. Lactis

Bifidobacterium Animalis Subsp.

Bifidobacterium Animalis Segment by Application

Medicine and Health Products

Food

Clinical Auxiliary Treatment

Animal Feed

Other

Bifidobacterium Animalis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bifidobacterium Animalis status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bifidobacterium Animalis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bifidobacterium Animalis significant trends, drivers, influence factors in global and regions.

6. To analyze Bifidobacterium Animalis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidobacterium Animalis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bifidobacterium Animalis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidobacterium Animalis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bifidobacterium Animalis market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bifidobacterium Animalis industry.

Chapter 3: Detailed analysis of Bifidobacterium Animalis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bifidobacterium Animalis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bifidobacterium Animalis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bifidobacterium Animalis Industry Trends Table 2. Bifidobacterium Animalis Industry Drivers Table 3. Bifidobacterium Animalis Industry Opportunities and Challenges Table 4. Bifidobacterium Animalis Industry Restraints Table 5. Global Bifidobacterium Animalis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bifidobacterium Animalis Revenue Share by Company (2021-2026) Table 7. Global Bifidobacterium Animalis Sales Volume by Company (t) & (2021-2026) Table 8. Global Bifidobacterium Animalis Sales Volume Share by Company (2021-2026) Table 9. Global Bifidobacterium Animalis Average Price (USD/t) of Company (2021-2026) Table 10. Global Bifidobacterium Animalis Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bifidobacterium Animalis Key Company Manufacturing Base & Headquarters Table 12. Global Bifidobacterium Animalis Company, Product Type & Application Table 13. Global Bifidobacterium Animalis Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bifidobacterium Animalis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Bifidobacterium Animalis Subsp. Lactis Table 18. Significant Companies of Bifidobacterium Animalis Subsp. Table 19. Global Bifidobacterium Animalis Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Bifidobacterium Animalis Sales Volume by Type (2021-2026) & (t) Table 21. Global Bifidobacterium Animalis Sales Volume by Type (2027-2032) & (t) Table 22. Global Bifidobacterium Animalis Sales Volume Share by Type (2021-2026) Table 23. Global Bifidobacterium Animalis Sales Volume Share by Type (2027-2032) Table 24. Global Bifidobacterium Animalis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bifidobacterium Animalis Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Bifidobacterium Animalis Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Bifidobacterium Animalis Sales Value Share by Type (2021-2026) Table 28. Global Bifidobacterium Animalis Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Medicine and Health Products Table 30. Significant Companies of Food Table 31. Significant Companies of Clinical Auxiliary Treatment Table 32. Significant Companies of Animal Feed Table 33. Significant Companies of Other Table 34. Global Bifidobacterium Animalis Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 35. Global Bifidobacterium Animalis Sales Volume by Application (2021-2026) & (t) Table 36. Global Bifidobacterium Animalis Sales Volume by Application (2027-2032) & (t) Table 37. Global Bifidobacterium Animalis Sales Volume Share by Application (2021-2026) Table 38. Global Bifidobacterium Animalis Sales Volume Share by Application (2027-2032) Table 39. Global Bifidobacterium Animalis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Bifidobacterium Animalis Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Bifidobacterium Animalis Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Bifidobacterium Animalis Sales Value Share by Application (2021-2026) Table 43. Global Bifidobacterium Animalis Sales Value Share by Application (2027-2032) Table 44. Global Bifidobacterium Animalis Sales by Region: 2021 VS 2025 VS 2032 (t) Table 45. Global Bifidobacterium Animalis Sales by Region (2021-2026) & (t) Table 46. Global Bifidobacterium Animalis Sales Market Share by Region (2021-2026) Table 47. Global Bifidobacterium Animalis Sales by Region (2027-2032) & (t) Table 48. Global Bifidobacterium Animalis Sales Market Share by Region (2027-2032) Table 49. Global Bifidobacterium Animalis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Bifidobacterium Animalis Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Bifidobacterium Animalis Sales Value Share by Region (2021-2026) Table 52. Global Bifidobacterium Animalis Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Bifidobacterium Animalis Sales Value Share by Region (2027-2032) Table 54. Global Bifidobacterium Animalis Market Average Price (USD/t) by Region (2021-2026) Table 55. Global Bifidobacterium Animalis Market Average Price (USD/t) by Region (2027-2032) Table 56. Global Bifidobacterium Animalis Sales by Country: 2021 VS 2025 VS 2032 (t) Table 57. Global Bifidobacterium Animalis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Bifidobacterium Animalis Sales by Country (2021-2026) & (t) Table 59. Global Bifidobacterium Animalis Sales Market Share by Country (2021-2026) Table 60. Global Bifidobacterium Animalis Sales by Country (2027-2032) & (t) Table 61. Global Bifidobacterium Animalis Sales Market Share by Country (2027-2032) Table 62. Global Bifidobacterium Animalis Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Bifidobacterium Animalis Sales Value Market Share by Country (2021-2026) Table 64. Global Bifidobacterium Animalis Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Bifidobacterium Animalis Sales Value Market Share by Country (2027-2032) Table 66. ADM Company Information Table 67. ADM Business Overview Table 68. ADM Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. ADM Bifidobacterium Animalis Product Portfolio Table 70. ADM Recent Development Table 71. ATCC Company Information Table 72. ATCC Business Overview Table 73. ATCC Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. ATCC Bifidobacterium Animalis Product Portfolio Table 75. ATCC Recent Development Table 76. Chr. Hansen Company Information Table 77. Chr. Hansen Business Overview Table 78. Chr. Hansen Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Chr. Hansen Bifidobacterium Animalis Product Portfolio Table 80. Chr. Hansen Recent Development Table 81. Creative Biolabs Company Information Table 82. Creative Biolabs Business Overview Table 83. Creative Biolabs Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Creative Biolabs Bifidobacterium Animalis Product Portfolio Table 85. Creative Biolabs Recent Development Table 86. DuPont Nutrition & Biosciences Company Information Table 87. DuPont Nutrition & Biosciences Business Overview Table 88. DuPont Nutrition & Biosciences Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. DuPont Nutrition & Biosciences Bifidobacterium Animalis Product Portfolio Table 90. DuPont Nutrition & Biosciences Recent Development Table 91. Fengchen Group Company Information Table 92. Fengchen Group Business Overview Table 93. Fengchen Group Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Fengchen Group Bifidobacterium Animalis Product Portfolio Table 95. Fengchen Group Recent Development Table 96. Microbiologics Company Information Table 97. Microbiologics Business Overview Table 98. Microbiologics Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Microbiologics Bifidobacterium Animalis Product Portfolio Table 100. Microbiologics Recent Development Table 101. Morinaga Company Information Table 102. Morinaga Business Overview Table 103. Morinaga Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Morinaga Bifidobacterium Animalis Product Portfolio Table 105. Morinaga Recent Development Table 106. SynBalance Company Information Table 107. SynBalance Business Overview Table 108. SynBalance Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. SynBalance Bifidobacterium Animalis Product Portfolio Table 110. SynBalance Recent Development Table 111. BGI Nutri Company Information Table 112. BGI Nutri Business Overview Table 113. BGI Nutri Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. BGI Nutri Bifidobacterium Animalis Product Portfolio Table 115. BGI Nutri Recent Development Table 116. Wecare Probiotics Company Information Table 117. Wecare Probiotics Business Overview Table 118. Wecare Probiotics Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Wecare Probiotics Bifidobacterium Animalis Product Portfolio Table 120. Wecare Probiotics Recent Development Table 121. Yili Group Company Information Table 122. Yili Group Business Overview Table 123. Yili Group Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. Yili Group Bifidobacterium Animalis Product Portfolio Table 125. Yili Group Recent Development Table 126. Wisbiom (Beijing) Biotechnology Company Information Table 127. Wisbiom (Beijing) Biotechnology Business Overview Table 128. Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 129. Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Product Portfolio Table 130. Wisbiom (Beijing) Biotechnology Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Bifidobacterium Animalis Distributors List Table 134. Bifidobacterium Animalis Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Bifidobacterium Animalis Product Image Figure 2. Global Bifidobacterium Animalis Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bifidobacterium Animalis Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bifidobacterium Animalis Sales (2021-2032) & (t) Figure 5. Global Bifidobacterium Animalis Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Bifidobacterium Animalis Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Bifidobacterium Animalis Subsp. Lactis Image Figure 10. Bifidobacterium Animalis Subsp. Image Figure 11. Global Bifidobacterium Animalis Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Bifidobacterium Animalis Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Bifidobacterium Animalis Sales Volume Share by Type (2021-2032) Figure 14. Global Bifidobacterium Animalis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bifidobacterium Animalis Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bifidobacterium Animalis Sales Value Share by Type (2021-2032) Figure 17. Medicine and Health Products Image Figure 18. Food Image Figure 19. Clinical Auxiliary Treatment Image Figure 20. Animal Feed Image Figure 21. Other Image Figure 22. Global Bifidobacterium Animalis Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Bifidobacterium Animalis Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Bifidobacterium Animalis Sales Volume Share by Application (2021-2032) Figure 25. Global Bifidobacterium Animalis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Bifidobacterium Animalis Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Bifidobacterium Animalis Sales Value Share by Application (2021-2032) Figure 28. Global Bifidobacterium Animalis Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 29. Global Bifidobacterium Animalis Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Bifidobacterium Animalis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Bifidobacterium Animalis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Bifidobacterium Animalis Sales Value (2021-2032) & (US$ Million) Figure 33. North America Bifidobacterium Animalis Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Bifidobacterium Animalis Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Bifidobacterium Animalis Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Bifidobacterium Animalis Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Bifidobacterium Animalis Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Bifidobacterium Animalis Sales Value (2021-2032) & (US$ Million) Figure 39. South America Bifidobacterium Animalis Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Bifidobacterium Animalis Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Bifidobacterium Animalis Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Bifidobacterium Animalis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Bifidobacterium Animalis Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Bifidobacterium Animalis Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Bifidobacterium Animalis Subsp. Lactis
  • Bifidobacterium Animalis Subsp.
Applications
  • Medicine and Health Products
  • Food
  • Clinical Auxiliary Treatment
  • Animal Feed
  • Other
Companies covered
  • ADM
  • ATCC
  • Chr. Hansen
  • Creative Biolabs
  • DuPont Nutrition & Biosciences
  • Fengchen Group
  • Microbiologics
  • Morinaga
  • SynBalance
  • BGI Nutri
  • Wecare Probiotics
  • Yili Group
  • Wisbiom (Beijing) Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bifidobacterium Animalis Sales Value (2021-2032)
  4. 1.2.2 Global Bifidobacterium Animalis Sales Volume (2021-2032)
  5. 1.2.3 Global Bifidobacterium Animalis Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bifidobacterium Animalis Market Dynamics
  1. 2.1 Bifidobacterium Animalis Industry Trends
  2. 2.2 Bifidobacterium Animalis Industry Drivers
  3. 2.3 Bifidobacterium Animalis Industry Opportunities and Challenges
  4. 2.4 Bifidobacterium Animalis Industry Restraints
3 Bifidobacterium Animalis Market by Company
  1. 3.1 Global Bifidobacterium Animalis Company Revenue Ranking in 2025
  2. 3.2 Global Bifidobacterium Animalis Revenue by Company (2021-2026)
  3. 3.3 Global Bifidobacterium Animalis Sales Volume by Company (2021-2026)
  4. 3.4 Global Bifidobacterium Animalis Average Price by Company (2021-2026)
  5. 3.5 Global Bifidobacterium Animalis Company Ranking (2024-2026)
  6. 3.6 Global Bifidobacterium Animalis Company Manufacturing Base and Headquarters
  7. 3.7 Global Bifidobacterium Animalis Company Product Type and Application
  8. 3.8 Global Bifidobacterium Animalis Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bifidobacterium Animalis Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bifidobacterium Animalis Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bifidobacterium Animalis Market by Type
  1. 4.1 Bifidobacterium Animalis Type Introduction
  2. 4.1.1 Bifidobacterium Animalis Subsp. Lactis
  3. 4.1.2 Bifidobacterium Animalis Subsp.
  4. 4.2 Global Bifidobacterium Animalis Sales Volume by Type
  5. 4.2.1 Global Bifidobacterium Animalis Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bifidobacterium Animalis Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Bifidobacterium Animalis Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Bifidobacterium Animalis Sales Value by Type
  9. 4.3.1 Global Bifidobacterium Animalis Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bifidobacterium Animalis Sales Value by Type (2021-2032)
  11. 4.3.3 Global Bifidobacterium Animalis Sales Value Share by Type (2021-2032)
5 Bifidobacterium Animalis Market by Application
  1. 5.1 Bifidobacterium Animalis Application Introduction
  2. 5.1.1 Medicine and Health Products
  3. 5.1.2 Food
  4. 5.1.3 Clinical Auxiliary Treatment
  5. 5.1.4 Animal Feed
  6. 5.1.5 Other
  7. 5.2 Global Bifidobacterium Animalis Sales Volume by Application
  8. 5.2.1 Global Bifidobacterium Animalis Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Bifidobacterium Animalis Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Bifidobacterium Animalis Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Bifidobacterium Animalis Sales Value by Application
  12. 5.3.1 Global Bifidobacterium Animalis Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Bifidobacterium Animalis Sales Value by Application (2021-2032)
  14. 5.3.3 Global Bifidobacterium Animalis Sales Value Share by Application (2021-2032)
6 Bifidobacterium Animalis Regional Sales and Value Analysis
  1. 6.1 Global Bifidobacterium Animalis Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bifidobacterium Animalis Sales by Region (2021-2032)
  3. 6.2.1 Global Bifidobacterium Animalis Sales by Region: 2021-2026
  4. 6.2.2 Global Bifidobacterium Animalis Sales by Region (2027-2032)
  5. 6.3 Global Bifidobacterium Animalis Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bifidobacterium Animalis Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bifidobacterium Animalis Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bifidobacterium Animalis Sales Value by Region (2027-2032)
  9. 6.5 Global Bifidobacterium Animalis Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bifidobacterium Animalis Sales Value (2021-2032)
  12. 6.6.2 North America Bifidobacterium Animalis Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bifidobacterium Animalis Sales Value (2021-2032)
  15. 6.7.2 Europe Bifidobacterium Animalis Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bifidobacterium Animalis Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bifidobacterium Animalis Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bifidobacterium Animalis Sales Value (2021-2032)
  21. 6.9.2 South America Bifidobacterium Animalis Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bifidobacterium Animalis Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bifidobacterium Animalis Sales Value Share by Country, 2025 VS 2032
7 Bifidobacterium Animalis Country-level Sales and Value Analysis
  1. 7.1 Global Bifidobacterium Animalis Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bifidobacterium Animalis Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bifidobacterium Animalis Sales by Country (2021-2032)
  4. 7.3.1 Global Bifidobacterium Animalis Sales by Country (2021-2026)
  5. 7.3.2 Global Bifidobacterium Animalis Sales by Country (2027-2032)
  6. 7.4 Global Bifidobacterium Animalis Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bifidobacterium Animalis Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bifidobacterium Animalis Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bifidobacterium Animalis Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bifidobacterium Animalis Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bifidobacterium Animalis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ADM
  2. 8.1.1 ADM Company Information
  3. 8.1.2 ADM Business Overview
  4. 8.1.3 ADM Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ADM Bifidobacterium Animalis Product Portfolio
  6. 8.1.5 ADM Recent Developments
  7. 8.2 ATCC
  8. 8.2.1 ATCC Company Information
  9. 8.2.2 ATCC Business Overview
  10. 8.2.3 ATCC Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ATCC Bifidobacterium Animalis Product Portfolio
  12. 8.2.5 ATCC Recent Developments
  13. 8.3 Chr. Hansen
  14. 8.3.1 Chr. Hansen Company Information
  15. 8.3.2 Chr. Hansen Business Overview
  16. 8.3.3 Chr. Hansen Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chr. Hansen Bifidobacterium Animalis Product Portfolio
  18. 8.3.5 Chr. Hansen Recent Developments
  19. 8.4 Creative Biolabs
  20. 8.4.1 Creative Biolabs Company Information
  21. 8.4.2 Creative Biolabs Business Overview
  22. 8.4.3 Creative Biolabs Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Creative Biolabs Bifidobacterium Animalis Product Portfolio
  24. 8.4.5 Creative Biolabs Recent Developments
  25. 8.5 DuPont Nutrition & Biosciences
  26. 8.5.1 DuPont Nutrition & Biosciences Company Information
  27. 8.5.2 DuPont Nutrition & Biosciences Business Overview
  28. 8.5.3 DuPont Nutrition & Biosciences Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DuPont Nutrition & Biosciences Bifidobacterium Animalis Product Portfolio
  30. 8.5.5 DuPont Nutrition & Biosciences Recent Developments
  31. 8.6 Fengchen Group
  32. 8.6.1 Fengchen Group Company Information
  33. 8.6.2 Fengchen Group Business Overview
  34. 8.6.3 Fengchen Group Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fengchen Group Bifidobacterium Animalis Product Portfolio
  36. 8.6.5 Fengchen Group Recent Developments
  37. 8.7 Microbiologics
  38. 8.7.1 Microbiologics Company Information
  39. 8.7.2 Microbiologics Business Overview
  40. 8.7.3 Microbiologics Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Microbiologics Bifidobacterium Animalis Product Portfolio
  42. 8.7.5 Microbiologics Recent Developments
  43. 8.8 Morinaga
  44. 8.8.1 Morinaga Company Information
  45. 8.8.2 Morinaga Business Overview
  46. 8.8.3 Morinaga Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Morinaga Bifidobacterium Animalis Product Portfolio
  48. 8.8.5 Morinaga Recent Developments
  49. 8.9 SynBalance
  50. 8.9.1 SynBalance Company Information
  51. 8.9.2 SynBalance Business Overview
  52. 8.9.3 SynBalance Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 SynBalance Bifidobacterium Animalis Product Portfolio
  54. 8.9.5 SynBalance Recent Developments
  55. 8.10 BGI Nutri
  56. 8.10.1 BGI Nutri Company Information
  57. 8.10.2 BGI Nutri Business Overview
  58. 8.10.3 BGI Nutri Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 BGI Nutri Bifidobacterium Animalis Product Portfolio
  60. 8.10.5 BGI Nutri Recent Developments
  61. 8.11 Wecare Probiotics
  62. 8.11.1 Wecare Probiotics Company Information
  63. 8.11.2 Wecare Probiotics Business Overview
  64. 8.11.3 Wecare Probiotics Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Wecare Probiotics Bifidobacterium Animalis Product Portfolio
  66. 8.11.5 Wecare Probiotics Recent Developments
  67. 8.12 Yili Group
  68. 8.12.1 Yili Group Company Information
  69. 8.12.2 Yili Group Business Overview
  70. 8.12.3 Yili Group Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Yili Group Bifidobacterium Animalis Product Portfolio
  72. 8.12.5 Yili Group Recent Developments
  73. 8.13 Wisbiom (Beijing) Biotechnology
  74. 8.13.1 Wisbiom (Beijing) Biotechnology Company Information
  75. 8.13.2 Wisbiom (Beijing) Biotechnology Business Overview
  76. 8.13.3 Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Product Portfolio
  78. 8.13.5 Wisbiom (Beijing) Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bifidobacterium Animalis Value Chain Analysis
  2. 9.1.1 Bifidobacterium Animalis Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bifidobacterium Animalis Sales Mode & Process
  6. 9.2 Bifidobacterium Animalis Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bifidobacterium Animalis Distributors
  9. 9.2.3 Bifidobacterium Animalis Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst